持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/08/19 | 3,520 | 3,560 | 3,520 | 3,545 | -25 | -0.7% | 36,900 |
| 2021/08/18 | 3,560 | 3,590 | 3,550 | 3,570 | +40 | +1.1% | 22,100 |
| 2021/08/17 | 3,510 | 3,565 | 3,500 | 3,530 | +40 | +1.1% | 38,600 |
| 2021/08/16 | 3,540 | 3,540 | 3,460 | 3,490 | -65 | -1.8% | 40,100 |
| 2021/08/13 | 3,510 | 3,570 | 3,510 | 3,555 | +40 | +1.1% | 21,300 |
| 2021/08/12 | 3,605 | 3,605 | 3,510 | 3,515 | -70 | -2% | 28,300 |
| 2021/08/11 | 3,575 | 3,610 | 3,565 | 3,585 | +55 | +1.6% | 35,400 |
| 2021/08/10 | 3,495 | 3,565 | 3,495 | 3,530 | +35 | +1% | 46,100 |
| 2021/08/06 | 3,495 | 3,540 | 3,480 | 3,495 | ±0 | ±0% | 25,200 |
| 2021/08/05 | 3,475 | 3,520 | 3,470 | 3,495 | +20 | +0.6% | 30,700 |
| 2021/08/04 | 3,500 | 3,535 | 3,475 | 3,475 | -25 | -0.7% | 45,500 |
| 2021/08/03 | 3,585 | 3,585 | 3,495 | 3,500 | -70 | -2% | 42,800 |
| 2021/08/02 | 3,585 | 3,610 | 3,560 | 3,570 | -15 | -0.4% | 64,300 |
| 2021/07/30 | 3,640 | 3,655 | 3,580 | 3,585 | -55 | -1.5% | 55,400 |
| 2021/07/29 | 3,665 | 3,675 | 3,640 | 3,640 | ±0 | ±0% | 24,900 |
| 2021/07/28 | 3,655 | 3,695 | 3,640 | 3,640 | -30 | -0.8% | 25,400 |
| 2021/07/27 | 3,680 | 3,690 | 3,645 | 3,670 | ±0 | ±0% | 27,800 |
| 2021/07/26 | 3,665 | 3,685 | 3,635 | 3,670 | +45 | +1.2% | 38,000 |
| 2021/07/21 | 3,640 | 3,655 | 3,605 | 3,625 | +35 | +1% | 28,500 |
| 2021/07/20 | 3,595 | 3,615 | 3,565 | 3,590 | -45 | -1.2% | 31,100 |
| 2021/07/19 | 3,600 | 3,640 | 3,590 | 3,635 | -10 | -0.3% | 39,100 |
| 2021/07/16 | 3,650 | 3,695 | 3,645 | 3,645 | -35 | -1% | 25,100 |
| 2021/07/15 | 3,775 | 3,775 | 3,680 | 3,680 | -50 | -1.3% | 45,200 |
| 2021/07/14 | 3,725 | 3,775 | 3,715 | 3,730 | +10 | +0.3% | 32,400 |
| 2021/07/13 | 3,690 | 3,730 | 3,680 | 3,720 | -5 | -0.1% | 35,500 |
| 2021/07/12 | 3,700 | 3,735 | 3,660 | 3,725 | +135 | +3.8% | 46,200 |
| 2021/07/09 | 3,575 | 3,600 | 3,525 | 3,590 | -55 | -1.5% | 69,400 |
| 2021/07/08 | 3,635 | 3,695 | 3,615 | 3,645 | -15 | -0.4% | 58,600 |
| 2021/07/07 | 3,585 | 3,660 | 3,565 | 3,660 | +10 | +0.3% | 68,700 |
| 2021/07/06 | 3,660 | 3,660 | 3,615 | 3,650 | +30 | +0.8% | 27,800 |
| 2021/07/05 | 3,635 | 3,655 | 3,610 | 3,620 | -15 | -0.4% | 19,900 |
| 2021/07/02 | 3,680 | 3,685 | 3,625 | 3,635 | -45 | -1.2% | 46,300 |
| 2021/07/01 | 3,655 | 3,685 | 3,645 | 3,680 | +40 | +1.1% | 40,600 |
| 2021/06/30 | 3,700 | 3,700 | 3,635 | 3,640 | -45 | -1.2% | 36,000 |
| 2021/06/29 | 3,690 | 3,715 | 3,660 | 3,685 | -55 | -1.5% | 66,300 |
| 2021/06/28 | 3,715 | 3,750 | 3,695 | 3,740 | +55 | +1.5% | 33,600 |
| 2021/06/25 | 3,720 | 3,725 | 3,665 | 3,685 | -35 | -0.9% | 51,900 |
| 2021/06/24 | 3,685 | 3,735 | 3,685 | 3,720 | -5 | -0.1% | 24,800 |
| 2021/06/23 | 3,765 | 3,805 | 3,725 | 3,725 | +20 | +0.5% | 71,000 |
| 2021/06/22 | 3,645 | 3,720 | 3,610 | 3,705 | +130 | +3.6% | 52,900 |
| 2021/06/21 | 3,580 | 3,595 | 3,555 | 3,575 | -15 | -0.4% | 60,700 |
| 2021/06/18 | 3,740 | 3,740 | 3,590 | 3,590 | -115 | -3.1% | 117,300 |
| 2021/06/17 | 3,730 | 3,765 | 3,700 | 3,705 | -10 | -0.3% | 36,200 |
| 2021/06/16 | 3,720 | 3,725 | 3,690 | 3,715 | -25 | -0.7% | 39,900 |
| 2021/06/15 | 3,770 | 3,770 | 3,700 | 3,740 | -10 | -0.3% | 35,100 |
| 2021/06/14 | 3,755 | 3,770 | 3,730 | 3,750 | +10 | +0.3% | 26,700 |
| 2021/06/11 | 3,755 | 3,755 | 3,705 | 3,740 | -5 | -0.1% | 48,200 |
| 2021/06/10 | 3,700 | 3,760 | 3,670 | 3,745 | +45 | +1.2% | 34,300 |
| 2021/06/09 | 3,680 | 3,710 | 3,660 | 3,700 | +35 | +1% | 19,600 |
| 2021/06/08 | 3,635 | 3,685 | 3,635 | 3,665 | +20 | +0.5% | 27,200 |
801～
850
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
